EICHORCondition: Acute Promyelocytic Leukemia With PML-RARA · t(15;17) · Sponsor: ECOG-ACRIN Cancer Research Group
This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Fairbanks Memorial Hospital | Fairbanks, Alaska, United States | — |
| Kaiser Permanente-Anaheim | Anaheim, California, United States | — |
| Kaiser Permanente-Deer Valley Medical Center | Antioch, California, United States | — |
| Kaiser Permanente-Baldwin Park | Baldwin Park, California, United States | — |
| Kaiser Permanente-Bellflower | Bellflower, California, United States | — |
| Kaiser Permanente-Fontana | Fontana, California, United States | — |
| Kaiser Permanente-Fremont | Fremont, California, United States | — |
| Fresno Cancer Center | Fresno, California, United States | — |
| Kaiser Permanente-Fresno | Fresno, California, United States | — |
| Kaiser Permanente - Harbor City | Harbor City, California, United States | — |
| Kaiser Permanente-Irvine | Irvine, California, United States | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
+ 282 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03253848